In the news | 29th June 2023
Overcoming the BioPharma paradox of advanced science and slow digital transformation
The BioPharma industry faces a paradox: while scientific innovation accelerates, digital transformation lags. Breaking this paradox requires a commitment to digital transformation, unlocking the industry’s potential for accelerating drug development and advancing human health.
Pietro Forgione, General Manager at IDBS, explores the paradox that the BioPharma industry is facing. Learn how advances in digital technology and the tailwinds of external forces offer the pharma industry a chance to break out of this paradox.